Timothy Rolph Akero Therapeutics, Inc. (AKRO) insider trading activity
Timothy Rolph is Chief Scientific Officer of Akero Therapeutics, Inc.. Currently has a direct ownership of 178,337 shares of AKRO, which is worth approximately $5.09 Million. The most recent transaction as insider was on Oct 25, 2022, when has been sold 10,000 shares (Common Stock) at a price of $17.36 per share, resulting in proceeds of $173,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
178K
1.31%
3M change
2.37%
12M change
Total Value Held
$5.09 Million
Timothy Rolph Transaction History
TR
Timothy Rolph
Chief Scientific Officer
South San Francisco, CA